top of page

Scientific Presentations & Publications

Skyhawk Presents at HDYO

March 15, 2025
HDYO International Congress 2025

SKY-0515: A Daily Pill Designed To Target The Cause Of Huntington's Disease With A Potential To Help Slow Its Progression

Skyhawk presents on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington’s Disease, to members of the Huntington’s Disease Youth Organization (HDYO), at the annual HYDO International Congress in Prague, Czech Republic on March 15th, 2025.

​

HDYO 2021 master logo.jpg
Small Molecules that Modify RNA Expression
Contact

Skyhawk Therapeutics, Inc.
180 3rd Ave., Fifth Floor
Waltham, MA 02451
United States

info@skyhawktx.com
1-617-858-0041

​

Skyhawk Therapeutics Europe, GmbH
Hochbergerstrasse 60I
Basel 4057 Switzerland
+41 (0) 61 512 15 20

​

​

​

Sitemap
  • X
  • LinkedIn

©2024 Skyhawk Therapeutics - All Rights Reserved

Skyhawk, SkyStar and triangle mark are federally registered trademarks owned by Skyhawk Therapeutics, Inc.

bottom of page